EU-HTA: G-BA coordinates parallel scientific consultations for manufacturers from September

3 July 2023 - From 2025, a systematic evaluation of clinical studies for new medicinal products and medical devices will ...

Read more →

CADTH expands scientific advice program to include advice on real world evidence

28 April 2022 - CADTH is expanding its scientific advice program to include applications for advice on real world evidence generation ...

Read more →

NICE provides first scientific advice on patient preference study design

14 February 2019 - The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided ...

Read more →

NICE collaborates with the Canadian Agency for Drugs and Technology in Health to offer parallel scientific advice

6 February 2019 - NICE and the Canadian Agency for Drugs and Technology in Health have launched a new collaboration to ...

Read more →

New opportunity: parallel scientific advice from CADTH and NICE

6 February 2019 - CADTH is pleased to announce a new collaboration with England’s NICE (National Institute for Health and ...

Read more →

NICE Scientific Advice launches collaborative programme with life sciences industry body

29 January 2019 - NICE has announced a collaboration with the body which represents life sciences organisations in the UK. ...

Read more →

Takeda pioneers NICE’s new service for economic model review

7 June 2018 - NICE Scientific Advice (NSA) launched a new health economic model review service, PRIMA, in December 2017 and ...

Read more →

Industry's experiences with the scientific advice offered by the Federal Joint Committee within the early benefit assessment of pharmaceuticals in Germany

19 February 2018 - Optional scientific advice for the early benefit assessment of pharmaceuticals is offered by the German decision maker, ...

Read more →